Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.

Esperanza Martín-Sánchez; Laura Blanco; Peter S Kim; Kamlesh Bisht; Hongfang Wang; Helgi Van de Velde; Tomas Jelinek; Catia Simoes; Felipe Prosper; Jesus F San Miguel; Ana Alfonso; Juan Bergua; Rebeca Rodríguez-Veiga; Susana Vives; David Martínez-Cuadrón; Pau Montesinos; Bruno Paiva; Aintzane Zabaleta